Prevalence of PROs was not significantly associated with other stakeholder engagement, and there did not seem to be a significant trend toward improvement over time.
← all excerpts
Patient-reported outcomes and target effect sizes in pragmatic randomized trials in ClinicalTrials.gov: A cross-sectional analysis.
1
—
—